Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges
ABSTRACT Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to treat and manage bacterial infection. The development and FDA approval of novel antibiotics have slowed over the past decade; therefore, the adoption and improvement of alternative therapeutic strat...
Enregistré dans:
Auteurs principaux: | Chih-Yuan Chiang, Ijeoma Uzoma, Richard T. Moore, Merle Gilbert, Allen J. Duplantier, Rekha G. Panchal |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7de0eec81d1e40dc8ff6383e4cf2aa95 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment-Resistant Bacterial Keratitis: Challenges and Solutions
par: Egrilmez S, et autres
Publié: (2020) -
Multiple antibiotic susceptibility of polyphosphate kinase mutants (ppk1 and ppk2) from Pseudomonas aeruginosa PAO1 as revealed by global phenotypic analysis
par: Ortiz-Severín,Javiera, et autres
Publié: (2015) -
Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review
par: Kawaljeet Kaur, et autres
Publié: (2021) -
Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria
par: Masadeh MM, et autres
Publié: (2021) -
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
par: Hye-Ra Lee, et autres
Publié: (2020)